首页> 外文期刊>JAMA: the Journal of the American Medical Association >Rates of treated and untreated kidney failure in older vs younger adults
【24h】

Rates of treated and untreated kidney failure in older vs younger adults

机译:年龄较大的肾功能衰竭治疗和未经治疗的肾功能衰竭

获取原文
获取原文并翻译 | 示例
       

摘要

Context: Studies of kidney failure in older adults have focused on receipt of dialysis, which may underestimate the burden of disease if older people are less likely to receive treatment. Objective: To determine the extent to which age is associated with the likelihood of treatment of kidney failure. Design, Setting, and Participants: Community-based cohort study of 1 816 824 adults in Alberta, Canada, who had outpatient estimated glomerular filtration rate (eGFR) measured between May 1, 2002, and March 31, 2008, with a baseline eGFR of 15 mL/min/1.73m 2 or higher and who did not require renal replacement therapy at baseline. Age was categorized as 18 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 or more years and eGFR as 90 or higher, 60 to 89, 45 to 59, 30 to 44, and 15 to 29 mL/min/1.73 m 2. Main Outcome Measures: Adjusted rates of treated kidney failure (receipt of dialysis or kidney transplantation), untreated kidney failure (progression to eGFR ?λτ?15 mL/min/1.73 m 2 without renal replacement therapy), and death. Results: During a median follow-up of 4.4 years, 97 451 (5.36%) died, 3295 (0.18%) developed kidney failure that was treated and 3116 (0.17%) developed kidney failure that went untreated. Within each eGFR stratum the rate of treated kidney failure was higher in younger compared with older people. For example, in the lowest eGFR stratum (15-29 mL/min/1.73 m 2), adjusted rates of treated kidney failure were more than 10-fold higher among the youngest (18-44 years) compared with the oldest (≥85 years) groups (adjusted rate, 24.00 [95% CI, 14.78-38.97] vs 1.53 [95% CI, 0.59-3.99] per 1000 person-years, respectively; P?λτ? .001). Rates of untreated kidney failure were consistently higher at older ages. In the eGFR stratum of 15 to 29 mL/min/1.73 m 2, adjusted rates of untreated kidney failure were more than 5-fold higher among the oldest (≥85 years), compared with the youngest (18-44 years) groups (adjusted rate, 19.95 [95% CI, 15.79-25.19] vs 3.53 [95% CI, 1.56-8.01] per 1000 person-years, respectively; P?λτ?.001). Rates of kidney failure overall (treated and untreated combined) demonstrated less variation across age groups; eg, the adjusted rate per 1000 person years for those with eGFR of 15-29 mL/min/1.73 m 2 was 36.45 (95% CI, 24.46-54.32) among participants aged 18 to 44 years and 20.19 (95% CI, 15.27-26.69) among those aged 85 years or older (P=.01). Conclusion: In Alberta, Canada, rates of untreated kidney failure are significantly higher in older compared with younger individuals.
机译:背景信息:老年人的肾功能衰竭的研究专注于收到透析,如果老年人不太可能接受治疗,可能会低估疾病的负担。目的:确定年龄与治疗肾衰竭的可能性有关的程度。设计,设定和参与者:加拿大艾伯塔省1816 824名成人的社区队列研究,他们在2002年5月1日至2008年3月31日之间进行了门诊估计的肾小球过滤率(EGFR),其中有一个基线EGFR 15毫升/分钟/ 1.73米2或更高,谁在基线下不需要肾脏替代疗法。年龄被分类为18至44,45至54,55至64,65至74,75至84岁,85岁或以上,eGFR为90或更高,60至89,45至59,30至44和15岁至29毫升/分钟/ 1.73米2.主要观察措施:调整治疗的肾功能衰竭率(透析或肾移植收到),未处理的肾功能衰竭(进展到EGFR?λτ?15ml / min / 1.73m 2没有肾脏替代治疗)和死亡。结果:在4.4岁的中间后续行动期间,97 451(5.36%)死亡,3295(0.18%)培养了治疗的肾功能衰竭,3116(0.17%)出现未经处理的肾功能衰竭。在每个EGFR层内,与老年人相比,较年轻的肾功能衰竭率较高。例如,在最低的EGFR层(15-29mL / min / 1.73m 2)中,与最旧的最年轻的治疗肾功能衰竭的治疗肾功能衰竭率高超过10倍(≥85多年)群(调整率,24.00 [95%CI,14.78-38.97] Vs 1.53分别为每1000人 - 多年的1.53 [95%CI,0.59-3.99]; p?λτ≤001)。年龄较大的肾功能衰竭的肾比值持续更高。在15至29ml / min / 1.73m 2的EGFR层中,与最年轻(≥85岁)相比,未经治疗的肾功能衰竭的调整后的未处理肾功能衰竭率高超过5倍,相比(18-44岁)调整率,19.95 [95%CI,15.79-25.19]与3.53 [95%CI,1.56-8.01]分别为1000人 - 年; P?λτ?.001)。整体(治疗和未经处理的合并)肾功能衰竭的速率越差越跨年龄群体的变异;例如,对于15-29毫升/分钟/ 1.73m 2,18至44岁的参与者,每1000人少年的调整率为15-29毫升/分钟/ 1.73 m 2,参与者为36.45(95%CI,24.46-54.32),20.19(95%CI,15.27 -26.69)在85岁或以上的人(p = .01)中。结论:在加拿大艾伯塔省,与年轻个体相比,未经治疗的肾功能衰竭的肝脏率明显更高。

著录项

  • 来源
  • 作者单位

    Department of Medicine University of Calgary Calgary AB Canada Department of Community Health;

    Department of Medicine University of Calgary Calgary AB Canada Department of Community Health;

    Department of Medicine University of Calgary Calgary AB Canada Department of Community Health;

    Department of Medicine University of Washington Seattle WA United States;

    Department of Epidemiology University of Alabama at Birmingham Birmingham AL United States;

    Department of Medicine University of Calgary Calgary AB Canada Department of Community Health;

    Department of Medicine University of Calgary Calgary AB Canada Libin Cardiovascular Institute;

    Department of Medicine University of Calgary Calgary AB Canada;

    Department of Medicine University of Calgary Calgary AB Canada;

    Department of Medicine University of Alberta Edmonton AB Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

  • 入库时间 2022-08-19 19:20:45

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号